Home

ABOUT

Editorial

PRESS RELEASES

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR

SUBSCRIBE

Market Reports

FDA

Executives

Funding

Non Profits

Hospitals

Acquisitions

Health

Biotechnology News Magazine

HomeUrologyTeleflex Integrates Medical Education and Training with Explorer Surgical to Expand Urologists’...

Teleflex Integrates Medical Education and Training with Explorer Surgical to Expand Urologists’ Access to Procedural Expertise

Innovative, cloud-based digital platform supports Urologists’ access to enhanced training with the UroLift® System through remote collaboration tools

MARKET REPORTS

United States Cardiovascular Devices Market 2021-2027

United States Cardiovascular Devices Market is projected to reach US$ 39.98 Billion by 2027 from US$ 25.34 Billion in 2020, growing with a CAGR of 6.73%

Global Cerebrospinal Fluid Drainage Catheter Market (2021 to 2027) – by Application, Type and Regional Outlook

The Global Cerebrospinal Fluid Drainage Catheter Market size is expected to reach $402.6 Million by 2027, rising at a market growth of 8.6% CAGR during the forecast period. For the treatment of hydrocephalus, placement of cerebral spinal fluid (CSF) shunt systems is becoming a common medical and life-saving procedure for the majority of the patients.

United States Insulin Delivery Devices Market Report 2021

This new report provides an in-depth assessment of the U.S insulin delivery devices market dynamics, opportunities, future road-map, competitive landscape and discusses major trends.

Global $45 Billion Endoscopy Market Insights & Forecasts to 2025

The global endoscopy market is predicted to reach US$45.28 billion in 2025, growing, at a CAGR of 7.50%, for the duration spanning 2021-2025.

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, has announced it is combining its leading industry clinical education with the digital platform of Explorer Surgical, a GHX company. This collaboration will provide Urologists expanded access to interactive training and remote learning opportunities for the Teleflex UroLift®System. 

The Explorer Live cloud-based digital platform communicates critical information through an interactive digital playbook, enabling surgical teams to access customized information for specific team roles. The platform facilitates UroLift System trainer collaboration with Urology surgical teams during live procedures from anywhere in the country through remote video connectivity. 
“Our clinical teams are able to reinforce the best practices and techniques for the UroLift System, and ultimately help clinicians become more proficient with the device so they can achieve better patient outcomes,” said Kevin Hardage, President and General Manager of Interventional Urology at Teleflex. “This innovative platform makes it easy for us to provide support where and when it is needed.” 
“We have seen a tremendous response to Explorer Live from both our teams out in the field and the medical community they serve. And we are excited to offer physicians high-quality remote learning opportunities that can increase BPH patient access to effective treatment with the UroLift System,” said  Dale Zunke, Director of Clinical Affairs at Teleflex. 
“We are pleased to support Teleflex in its commitment to achieving the best outcomes for patients,” said Jennifer Fried, general manager, Explorer Surgical, a GHX company. “This is an exciting opportunity  for us to showcase how useful the platform can be in the urology specialty and demonstrate the need  for innovative workflow and case support tools.” 
With Explorer Live, all the processes and workflows of the UroLift System procedure are accessible before a surgical team performs any procedure. Through the platform, surgeons can: 
  • Access images, PDFs, and videos about the UroLift System, surgical techniques, and a step-by-step workflow for each team member. The digital playbook is customized to the clinical team’s role, procedure type, and surgeon preferences. 
  • Broadcast in real-time to provide clinical education, remote collaboration, or demonstrations. 
  • Capture robust video and procedural data to be used by the surgeon or in partnership with a  medical device company for performance tracking, identifying opportunities to reduce variability, post-market feedback and analysis, and future product development.  
The UroLift System is a minimally invasive treatment for lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). It can result in rapid relief and recovery for men living with symptoms of an enlarged prostate,1 and provides an alternative therapy with a risk profile better than reported for surgical procedures such as TURP.2 The UroLift permanent implants are delivered during an outpatient procedure and relieve prostate obstruction without cutting, heating, or removing prostate tissue.
spot_img

DON'T MISS

Saranas® Announces Initial Enrollment of SAFE-MCS Clinical Trial

The first patient was enrolled at Atlantic Health System’s Morristown Medical Center in Morristown, NJ, by Dr. Philippe Généreux, Co-Director of the Structural Heart Program, and Dr. Dimitrios Karmpaliotis, Medical Director of the Cardiovascular Rescue and Recovery Program and the Advanced Coronary Therapeutics and Chronic Total Occlusions Program, at Morristown Medical Center.

Cancer Patients Overlooked in COVID-19 Vaccine Rollout

For the new study, researchers sought to determine the proportion of states that elected to follow CDC recommendations. They identified every states’ COVID vaccination webpage through keyword-based internet search and set out to identify information about vaccination for cancer patients.

MRI Reveals Altered Brain Structure in Fetuses Exposed to Alcohol

For the study, researchers recruited 500 pregnant women who were referred for a fetal MRI for clinical reasons. On an anonymous questionnaire, 51of the women admitted to consuming alcohol during their pregnancy.

Popular Blood Thinners May Lead to Brain Bleeding after Head Injury

A three-year study of more than 1,000 patients found that the risk of delayed intracranial hemorrhage and death following head trauma was significantly higher for adults taking older blood-thinning medications.

Our Sister Publication: Biotechnology News Magazine

By using this website you agree to accept Medical Device News Magazine Privacy Policy